Thyroid Hormones and Cardiovascular Function and Diseases.
暂无分享,去创建一个
B. Biondi | A. Zaman | R. Peeters | I. Klein | A. Pingitore | S. Razvi | G. Iervasi | S. Danzi | Avais Jabbar
[1] Shangtong Lei. Interpretation for surgical section of 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis , 2018 .
[2] Фадеев Валентин Викторович,et al. Review of American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. , 2017 .
[3] O. Franco,et al. Association of Thyroid Function With Life Expectancy With and Without Cardiovascular Disease: The Rotterdam Study , 2017, JAMA internal medicine.
[4] Amit Kumar,et al. Usefulness of Serum Triiodothyronine (T3) to Predict Outcomes in Patients Hospitalized With Acute Heart Failure. , 2017, The American journal of cardiology.
[5] Wei Fang,et al. Free Triiodothyronine Level Correlates with Myocardial Injury and Prognosis in Idiopathic Dilated Cardiomyopathy: Evidence from Cardiac MRI and SPECT/PET Imaging , 2016, Scientific Reports.
[6] Indhu Aynipullya Jayasingh,et al. Subclinical hypothyroidism and the risk of hypercholesterolemia , 2016, Journal of family medicine and primary care.
[7] T. Kirkwood,et al. Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study , 2016, The Journal of clinical endocrinology and metabolism.
[8] T. Anzai,et al. Subclinical hypothyroidism is an independent predictor of adverse cardiovascular outcomes in patients with acute decompensated heart failure , 2016, ESC heart failure.
[9] P. Grigolini,et al. Cardioprotection and thyroid hormones , 2016, Heart Failure Reviews.
[10] I. Klein,et al. Thyroid Disease and the Heart. , 2016, Current problems in cardiology.
[11] A. Belló-Klein,et al. Thyroid hormones improve cardiac function and decrease expression of pro-apoptotic proteins in the heart of rats 14 days after infarction , 2016, Apoptosis.
[12] B. Nygaard,et al. Long‐term L‐Triiodothyronine (T3) treatment in stable systolic heart failure patients: a randomised, double‐blind, cross‐over, placebo‐controlled intervention study , 2015, Clinical endocrinology.
[13] D. Schlessinger,et al. No evidence of association between subclinical thyroid disorders and common carotid intima medial thickness or atherosclerotic plaque. , 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[14] E. Fliers,et al. Thyroid function in critically ill patients. , 2015, The lancet. Diabetes & endocrinology.
[15] L. Hegedüs,et al. The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism , 2015, European Thyroid Journal.
[16] Pingan Chen,et al. Free Triiodothyronine Levels and Short-Term Prognosis in Chronic Heart Failure Patients With Type 2 Diabetes , 2015, The American journal of the medical sciences.
[17] T. Jernberg,et al. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. , 2015, European heart journal.
[18] A. Zaman,et al. Thyroxine in acute myocardial infarction (ThyrAMI) - levothyroxine in subclinical hypothyroidism post-acute myocardial infarction: study protocol for a randomised controlled trial , 2015, Trials.
[19] Connie M. Rhee,et al. A review: Radiographic iodinated contrast media-induced thyroid dysfunction. , 2015, The Journal of clinical endocrinology and metabolism.
[20] S. Razvi,et al. Thyroid disease and vascular risk. , 2014, Clinical medicine.
[21] G. Berghe. Non-Thyroidal Illness in the ICU: A Syndrome with Different Faces , 2014 .
[22] O. Franco,et al. Subclinical thyroid dysfunction and the risk of stroke: a systematic review and meta-analysis , 2014, European Journal of Epidemiology.
[23] P. Larsen,et al. N-acetylcysteine administration prevents nonthyroidal illness syndrome in patients with acute myocardial infarction: a randomized clinical trial. , 2014, The Journal of clinical endocrinology and metabolism.
[24] L. Pitto,et al. Triiodothyronine prevents cardiac ischemia/reperfusion mitochondrial impairment and cell loss by regulating miR30a/p53 axis. , 2014, Endocrinology.
[25] S. Mooijaart. Letter regarding the Paper by Pearce et al. Entitled ‘2013 ETA Guideline: Management of Subclinical Hypothyroidism' , 2014, European Thyroid Journal.
[26] J. Olesen,et al. Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study. , 2014, The Journal of clinical endocrinology and metabolism.
[27] A. Zaman,et al. Blood thrombogenicity is independently associated with serum TSH levels in post-non-ST elevation acute coronary syndrome. , 2014, The Journal of clinical endocrinology and metabolism.
[28] I. Komuro,et al. Circulating p53-Responsive MicroRNAs Are Predictive Indicators of Heart Failure After Acute Myocardial Infarction , 2013, Circulation research.
[29] Daniel B Mark,et al. Thyroid function in heart failure and impact on mortality. , 2013, JACC. Heart failure.
[30] B. Biondi. Mechanisms in endocrinology: Heart failure and thyroid dysfunction. , 2012, European journal of endocrinology.
[31] R. Luben,et al. Subclinical Thyroid Dysfunction and the Risk of Heart Failure Events: An Individual Participant Data Analysis From 6 Prospective Cohorts , 2012, Circulation.
[32] J. Franklyn,et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. , 2012, Archives of internal medicine.
[33] S. Pearce,et al. Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. , 2012, Archives of internal medicine.
[34] B. Biondi,et al. Subclinical thyroid disease , 2012, The Lancet.
[35] Connie M. Rhee,et al. Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism. , 2012, Archives of internal medicine.
[36] V. Lorenzoni,et al. Persistence of Mortality Risk in Patients With Acute Cardiac Diseases and Mild Thyroid Dysfunction , 2012, The American journal of the medical sciences.
[37] K. Cao,et al. Negative association between free triiodothyronine level and international normalized ratio in euthyroid subjects with acute myocardial infarction , 2011, Acta Pharmacologica Sinica.
[38] L. Hegedüs,et al. A critical review and meta-analysis of the association between overt hyperthyroidism and mortality. , 2011, European journal of endocrinology.
[39] Yunfei Cai,et al. Blood pressure levels in patients with subclinical thyroid dysfunction: a meta-analysis of cross-sectional data , 2011, Hypertension Research.
[40] G. Lippi,et al. Hyperthyroidism and Venous Thrombosis: A Casual or Causal Association? A Systematic Literature Review , 2011, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[41] H. Biter,et al. Prevalence of Subclinical Hypothyroidism among Patients with Acute Myocardial Infarction , 2011, ISRN endocrinology.
[42] M. Dimopoulos,et al. Thyroid hormone and recovery of cardiac function in patients with acute myocardial infarction: a strong association? , 2011, European journal of endocrinology.
[43] I. Mourouzis,et al. Thyroid Hormone and Cardiac Disease: From Basic Concepts to Clinical Application , 2011, Journal of thyroid research.
[44] T. Şahin,et al. Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis. , 2011, Endocrine journal.
[45] W. Paulus,et al. Left-ventricular remodeling after myocardial infarction is associated with a cardiomyocyte-specific hypothyroid condition. , 2011, Endocrinology.
[46] B. Biondi,et al. Cardiovascular involvement in patients with different causes of hyperthyroidism , 2010, Nature Reviews Endocrinology.
[47] Herng‐Ching Lin,et al. Hyperthyroidism and Risk of Ischemic Stroke in Young Adults: A 5-Year Follow-Up Study , 2010, Stroke.
[48] M. Vanderpump,et al. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. , 2010, The Journal of clinical endocrinology and metabolism.
[49] P. Lavori,et al. Response to Letter Regarding Article, “DITPA (3,5-Diiodothyropropionic Acid), a Thyroid Hormone Analog to Treat Heart Failure: Phase II Trial Veterans Affairs Cooperative Study” , 2010 .
[50] R. Luben,et al. Initial thyroid status and cardiovascular risk factors: The EPIC‐Norfolk prospective population study , 2010, Clinical endocrinology.
[51] A. Pingitore,et al. The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence , 2010, Heart Failure Reviews.
[52] F. Laurindo,et al. Thyroid hormone stimulates NO production via activation of the PI3K/Akt pathway in vascular myocytes. , 2010, Cardiovascular research.
[53] V. Lionetti,et al. Early long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodelling in rats , 2010, Journal of cellular and molecular medicine.
[54] Jincheng Li,et al. miR-30 Regulates Mitochondrial Fission through Targeting p53 and the Dynamin-Related Protein-1 Pathway , 2010, PLoS genetics.
[55] E. Olson,et al. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. , 2009, Developmental cell.
[56] U. John,et al. Subclinical hyperthyroidism and blood pressure in a population-based prospective cohort study. , 2009, European journal of endocrinology.
[57] Claes Held,et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.
[58] M. Emdin,et al. Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure. , 2009, Journal of cardiac failure.
[59] P. Renard,et al. Thyroid hormone improves postischaemic recovery of function while limiting apoptosis: a new therapeutic approach to support hemodynamics in the setting of ischaemia-reperfusion? , 2009, Basic Research in Cardiology.
[60] W. Dillmann. Cardiac hypertrophy and thyroid hormone signaling , 2009, Heart Failure Reviews.
[61] C. Forleo,et al. Prognostic role of sub-clinical hypothyroidism in chronic heart failure outpatients. , 2008, Current pharmaceutical design.
[62] H. Völzke,et al. The association of thyroid function with carotid artery plaque burden and strokes in a population-based sample from a previously iodine-deficient area. , 2008, European journal of endocrinology.
[63] T. Visser,et al. Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. , 2008, Molecular endocrinology.
[64] A. L'Abbate,et al. Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. , 2008, The Journal of clinical endocrinology and metabolism.
[65] K. Kopecky,et al. Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid disease: implications for the diagnosis of subclinical hypothyroidism. , 2008, The Journal of clinical endocrinology and metabolism.
[66] B. Biondi,et al. The clinical significance of subclinical thyroid dysfunction. , 2008, Endocrine reviews.
[67] R. H. Costa-e-Sousa,et al. Thyroid function disturbance and type 3 iodothyronine deiodinase induction after myocardial infarction in rats a time course study. , 2007, Endocrinology.
[68] H. Vierhapper,et al. Altered platelet plug formation in hyperthyroidism and hypothyroidism. , 2007, The Journal of clinical endocrinology and metabolism.
[69] A. L'Abbate,et al. Association between increased mortality and mild thyroid dysfunction in cardiac patients. , 2007, Archives of internal medicine.
[70] H. Saconato,et al. Thyroid hormone replacement for subclinical hypothyroidism. , 2007, The Cochrane database of systematic reviews.
[71] R. Sabit,et al. Thyroid disease and vascular function. , 2007, Thyroid : official journal of the American Thyroid Association.
[72] J. Weaver,et al. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. , 2007, The Journal of clinical endocrinology and metabolism.
[73] C. Lau,et al. Hemodynamic changes in hyperthyroidism-related pulmonary hypertension: a prospective echocardiographic study. , 2007, The Journal of clinical endocrinology and metabolism.
[74] C. Xinaris,et al. Enhanced tolerance of the rat myocardium to ischemia and reperfusion injury early after acute myocardial infarction , 2007, Basic Research in Cardiology.
[75] L. Vatten,et al. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. , 2007, European journal of endocrinology.
[76] L. Ghiadoni,et al. Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis. , 2006, The Journal of clinical endocrinology and metabolism.
[77] U. John,et al. The association between subclinical hyperthyroidism and blood pressure in a population-based study , 2006, Journal of hypertension.
[78] G. Cella,et al. Hyperthyroidism as a Cause of Pulmonary Arterial Hypertension: A Prospective Study , 2006, Angiology.
[79] M. Emdin,et al. Early activation of an altered thyroid hormone profile in asymptomatic or mildly symptomatic idiopathic left ventricular dysfunction. , 2006, Journal of cardiac failure.
[80] R. Delsignore,et al. Pulmonary hypertension is frequent in hyperthyroidism and normalizes after therapy. , 2006, European journal of internal medicine.
[81] R. Jorde,et al. Serum lipid levels in relation to serum thyroid‐stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study , 2006, Journal of internal medicine.
[82] C. Erem. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity , 2006, Clinical endocrinology.
[83] U. John,et al. Low serum thyrotropin is associated with high plasma fibrinogen. , 2006, The Journal of clinical endocrinology and metabolism.
[84] Peter O'Leary,et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. , 2005, Archives of internal medicine.
[85] E. Vittinghoff,et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. , 2005, Archives of internal medicine.
[86] C. Long,et al. Thyroid hormone induces cardiac myocyte hypertrophy in a thyroid hormone receptor alpha1-specific manner that requires TAK1 and p38 mitogen-activated protein kinase. , 2005, Molecular endocrinology.
[87] S. Guldıken,et al. Global fibrinolytic capacity in patients with subclinical hypothyroidism. , 2005, Endocrine journal.
[88] N. Kamel,et al. Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism. , 2005, European journal of endocrinology.
[89] N. Osman,et al. Does subclinical hypothyroidism affect cardiac pump performance? Evidence from a magnetic resonance imaging study. , 2005, Journal of the American College of Cardiology.
[90] A. L'Abbate,et al. Triiodothyronine levels for risk stratification of patients with chronic heart failure. , 2005, The American journal of medicine.
[91] Paul Webb,et al. Thyroxine-Thyroid Hormone Receptor Interactions* , 2004, Journal of Biological Chemistry.
[92] A. D. de Craen,et al. Thyroid status, disability and cognitive function, and survival in old age. , 2004, JAMA.
[93] P. Vestergaard,et al. Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. , 2004, Archives of internal medicine.
[94] J. Kvetny,et al. Subclinical hypothyroidism is associated with a low‐grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years , 2004, Clinical endocrinology.
[95] A. Hida,et al. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. , 2004, The Journal of clinical endocrinology and metabolism.
[96] V. Palmieri,et al. Myocardial contractility and total arterial stiffness in patients with overt hyperthyroidism: acute effects of beta1-adrenergic blockade. , 2004, European journal of endocrinology.
[97] U. John,et al. Thyroid function and carotid wall thickness. , 2004, The Journal of clinical endocrinology and metabolism.
[98] C. Palombo,et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. , 2004, The Journal of clinical endocrinology and metabolism.
[99] P. Thompson,et al. Treating hypothyroidism improves endothelial function. , 2004, Metabolism: clinical and experimental.
[100] I. Klein,et al. Thyroid hormone and blood pressure regulation , 2003, Current hypertension reports.
[101] C. Duman,et al. Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. , 2003, Thyroid : official journal of the American Thyroid Association.
[102] L. Ghiadoni,et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. , 2003, The Journal of clinical endocrinology and metabolism.
[103] P. Ladenson,et al. Hypothyroidism and atherosclerosis. , 2003, The Journal of clinical endocrinology and metabolism.
[104] C. Erem,et al. BLOOD COAGULATION AND FIBRINOLYTIC ACTIVITY IN HYPOTHYROIDISM , 2003, International journal of clinical practice.
[105] A. L'Abbate,et al. Low-T3 Syndrome: A Strong Prognostic Predictor of Death in Patients With Heart Disease , 2003, Circulation.
[106] Joshua R. Smith,et al. Increased central arterial stiffness in hypothyroidism. , 2002, The Journal of clinical endocrinology and metabolism.
[107] T. Visser,et al. Induction of thyroid hormone-degrading deiodinase in cardiac hypertrophy and failure. , 2002, Endocrinology.
[108] L. Friberg,et al. Rapid down-regulation of thyroid hormones in acute myocardial infarction: is it cardioprotective in patients with angina? , 2002, Archives of internal medicine.
[109] J. Dernellis,et al. Effects of thyroid replacement therapy on arterial blood pressure in patients with hypertension and hypothyroidism. , 2002, American heart journal.
[110] L. Duntas. Thyroid disease and lipids. , 2002, Thyroid : official journal of the American Thyroid Association.
[111] L. Friberg,et al. Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction. , 2001, The American journal of medicine.
[112] J. Franklyn,et al. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study , 2001, The Lancet.
[113] T. Kanda,et al. Correlation of circulating interleukin-10 with thyroid hormone in acute myocardial infarction. , 2001, Research communications in molecular pathology and pharmacology.
[114] E. Ferrannini,et al. Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. , 2001, The Journal of clinical endocrinology and metabolism.
[115] B. Müller,et al. Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease , 2001, European journal of clinical investigation.
[116] P. Giral,et al. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. , 2001, The Journal of clinical endocrinology and metabolism.
[117] T. Tzotzas,et al. Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment. , 2000, Thyroid : official journal of the American Thyroid Association.
[118] T. Kanda,et al. Involvement of circulating interleukin-6 and its receptor in the development of euthyroid sick syndrome in patients with acute myocardial infarction. , 2000, European journal of endocrinology.
[119] G. Canaris,et al. The Colorado thyroid disease prevalence study. , 2000, Archives of internal medicine.
[120] A. Hofman,et al. Subclinical Hypothyroidism Is an Independent Risk Factor for Atherosclerosis and Myocardial Infarction in Elderly Women: The Rotterdam Study , 2000, Annals of Internal Medicine.
[121] B. Biondi,et al. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. , 1999, The Journal of clinical endocrinology and metabolism.
[122] C. Morillas,et al. Effect of thyroid hormone replacement on lipoprotein(a), lipids, and apolipoproteins in subjects with hypothyroidism. , 1998, Mayo Clinic proceedings.
[123] T. Bucciarelli,et al. Effect of thyroid function on LDL oxidation. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[124] J. Lekakis,et al. Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. , 1997, Thyroid : official journal of the American Thyroid Association.
[125] F. B. Davis,et al. Nongenomic actions of thyroid hormone. , 1996, Thyroid : official journal of the American Thyroid Association.
[126] R. Westendorp,et al. Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies , 1996, Clinical endocrinology.
[127] J. Franklyn,et al. Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. , 1996, Heart.
[128] S. Thomas,et al. Thyroid hormone treatment after coronary-artery bypass surgery. , 1995, The New England journal of medicine.
[129] F. Sánchez‐Madrid,et al. Expression of vascular adhesion molecules on human endothelia in autoimmune thyroid disorders , 1995, Clinical and experimental immunology.
[130] D. Appleton,et al. LIPID PROFILES AND CARDIOVASCULAR DISEASE IN THE WHICKHAM AREA WITH PARTICULAR REFERENCE TO THYROID FAILURE , 1977, Clinical endocrinology.
[131] J. Jiskra,et al. [Thyroid hormones and cardiovascular system]. , 2018, Vnitrni lekarstvi.
[132] A. Zaman,et al. Thyroid hormones and cardiovascular disease , 2017, Nature Reviews Cardiology.
[133] I. Erdinler,et al. Sick euthyroid syndrome is associated with poor prognosis in patients with ST segment elevation myocardial infarction undergoing primary percutaneous intervention. , 2014, Cardiology journal.
[134] G. Van den Berghe. Non-thyroidal illness in the ICU: a syndrome with different faces. , 2014, Thyroid : official journal of the American Thyroid Association.
[135] G. Brabant,et al. ETA Guideline : Management of Subclinical Hypothyroidism , 2013 .
[136] Yawei Xu,et al. A low fT3 level as a prognostic marker in patients with acute myocardial infarctions. , 2012, Internal medicine.
[137] I. Klein. Endocrine Disorders and Cardiovascular Disease , 2012 .
[138] H. Büller,et al. Thyroid disease and haemostasis : a relationship with clinical implications ? , 2010 .
[139] I. Klein,et al. Effects of amiodarone therapy on thyroid function , 2010, Nature Reviews Endocrinology.
[141] M. Schott. Acute Effects of Triiodothyronine (T3) Replacement Therapy in Patients with Chronic Heart Failure and Low-T3 Syndrome: A Randomized, Placebo-Controlled Study , 2008 .
[142] E. Mazzaferri. Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults , 2007 .
[143] B. Biondi,et al. Effects of thyroid hormone on the cardiovascular system. , 2004, Recent progress in hormone research.
[144] L. J. Groot,et al. Dangerous Dogmas in Medicine: The Nonthyroidal Illness Syndrome , 1999 .
[145] L. D. De Groot. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. , 1999, The Journal of clinical endocrinology and metabolism.
[146] W. Wiersinga. Propranolol and thyroid hormone metabolism. , 1991, Thyroid : official journal of the American Thyroid Association.
[147] H. L. Bleich,et al. Thyroid-pituitary interaction: feedback regulation of thyrotropin secretion by thyroid hormones. , 1982, The New England journal of medicine.
[148] W M Wiersinga,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Increased Oxidizability of Low-Density Lipoproteins , 2022 .